Radius Health Inc (RDUS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
George K. Martin
Employees:
290
ATTN: CHIEF FINANCIAL OFFICER, 950 WINTER STREET, WALTHAM, MA 02451
617-551-4000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. The company is also developing a transdermal system that is in Phase III clinical trials to treat post menopausal women. It has collaborations and license agreements with 3M Company, Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. and Duke University.

Data derived from most recent annual or quarterly report
Market Cap 479.813 Million Shares Outstanding47.601 Million Avg 30-day Volume 1.89 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-15.749 Million
Price to Revenue2.2094 Debt to Equity-1.242 EBITDA-47.621 Million
Price to Book Value0.0 Operating Margin-22.709699999999998 Enterprise Value760.004 Million
Current Ratio1.666 EPS Growth-1 Quick Ratio1.124
1 Yr BETA 0.9132 52-week High/Low 23.0 / 4.97 Profit Margin-30.7247
Operating Cash Flow Growth55.6249 Altman Z-Score-11.1724 Free Cash Flow to Firm -17.523 Million
View SEC Filings from RDUS instead.

View recent insider trading info

Funds Holding RDUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RDUS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-02:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2022-07-28:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-27:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-22:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-08:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BIOTECH TARGET N V

    BB BIOTECH AG

    • 10% Owner
    0 2022-08-15 3

    GARNIER JEAN PIERRE

    • Director
    0 2022-08-15 2

    DERE WILLARD H

    • Director
    0 2022-08-15 2

    FRIEDMAN CATHY

    • Director
    0 2022-08-15 2

    VON ESCHENBACH ANDREW C.

    • Director
    0 2022-08-15 2

    HUGHES OWEN

    • Director
    0 2022-08-15 2

    MARTIN G. KELLY CEO AND PRESIDENT

    • Officer
    • Director
    0 2022-08-15 3

    JARRETT JENNIFER

    • Director
    0 2022-08-15 3

    MURPHY SEAN

    • Director
    0 2022-08-15 2

    SANDERS MACHELLE

    • Director
    0 2022-08-15 2

    SHAH CHHAYA CHIEF BUSINESS OFFICER

    • Officer
    0 2022-08-15 2

    HOLTSCHLAG DANIELLE VICE PRESIDENT, SALES

    • Officer
    0 2022-08-15 2

    MESSERSMITH ELIZABETH SENIOR VICE PRESIDENT

    • Officer
    0 2022-08-15 2

    LISA SUSAN VISSERS

    • Director
    0 2022-08-15 3

    RUBRIC CAPITAL MANAGEMENT LP

    ROSEN DAVID EFRAIM

    • 10% Owner
    8,642,271 2022-08-10 6

    CONLEY MARK WILLIAM VP, CHIEF FINANCIAL OFFICER

    • Officer
    50,000 2022-03-15 2

    HELWIG STEVEN PRINCIPAL FINANCIAL OFFICER

    • Officer
    31,251 2022-01-14 1

    RUBRIC CAPITAL MANAGEMENT LP

    • 10% Owner
    4,756,876 2021-12-08 6

    CHOPAS JAMES GEORGE PRINCIPAL FINANCE ACCOUNTING

    • Officer
    6,701 2021-03-05 0

    GRAUSSO SAL CHIEF COMMERCIAL OFFICER

    • Officer
    11,709 2021-02-25 0

    DOLAN DAN VP OF FINANCE

    • Officer
    0 2020-11-09 0

    ROSENBERG ANTHONY

    • Director
    12,401 2020-02-26 0

    MORRIS CHARLES Q CHIEF MEDICAL OFFICER

    • Officer
    33,744 2020-02-26 0

    CARMONA JOSE CHIEF FINANCIAL OFFICER

    • Officer
    46,708 2020-02-26 0

    KELLY JOSEPH FRANCIS SR. VP OF SALES AND MARKETING

    • Officer
    24,111 2020-02-26 0

    GRAVES KURT

    • Director
    11,000 2020-02-20 0

    HOPFIELD JESSICA

    • Director
    18,300 2020-02-20 0

    HOEILAND JESPER PRESIDENT AND CEO

    • Officer
    • Director
    0 2020-02-20 0

    BIOTECH GROWTH N V

    BB BIOTECH AG

    • 10% Owner
    6,881,685 2019-11-06 0

    ROYCHOWDHURY DEBASISH

    • Director
    5,500 2019-04-11 0

    HATZIS-SCHOCH BRENT SR. VP, GENERAL COUNSEL

    • Officer
    17,944 2019-02-22 0

    HATTERSLEY GARY CHIEF SCIENTIFIC OFFICER

    • Officer
    No longer subject to file 2018-12-31 0

    FITZPATRICK LORRAINE A. CHIEF MEDICAL OFFICER

    • Officer
    No longer subject to file 2018-12-31 0

    WILLIAMS GREGORY C. CHIEF DEVELOPMENT OFFICER

    • Officer
    0 2018-02-13 0

    SNOW DAVID P. CHIEF COMMERCIAL OFFICER

    • Officer
    No longer subject to file 2017-12-31 0

    HARVEY BRIAN NICHOLAS SR. VP AND CFO

    • Officer
    76,189 2017-04-25 0

    GADICKE ANSBERT

    • Director
    0 2017-02-17 0

    AUERBACH ALAN H

    • Director
    0 2017-02-17 0

    WARD ROBERT PRESIDENT & CEO

    • Officer
    • Director
    0 2017-02-17 0

    PURANDARE DINESH SVP, HEAD OF GLOBAL ONCOLOGY

    • Officer
    0 2017-02-17 0

    EVNIN LUKE

    • FORMER 10% STOCKHOLDER
    No longer subject to file 2016-09-27 0

    MPM BIOVENTURES III LLC

    HENNER DENNIS

    MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC

    MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

    MPM BIOVENTURES III PARALLEL FUND, L.P.

    MPM BIOVENTURES III GP L.P.

    MPM BIOVENTURES III L.P.

    MPM BIOVENTURES III-QP L.P.

    STEINMETZ MICHAEL

    • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
    No longer subject to file 2016-09-27 0

    MPM BIOVENTURES IV LLC

    SCOPA JAMES PAUL

    MPM BIOVENTURES IV GP LLC

    MPM BIO IV NVS STRATEGIC FUND LP

    KAILIAN VAUGHN M

    FOLEY TODD

    • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
    No longer subject to file 2016-09-27 0

    GALAKATOS NICHOLAS

    SIMON NICHOLAS J III

    WHEELER KURT

    • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
    No longer subject to file 2016-09-27 0

    WARD ROB PRESIDENT & CEO

    • Officer
    • Director
    0 2015-10-21 0

    MUENCHBACH MARTIN

    • Director
    0 2015-05-07 0

    F2 BIOSCIENCE III, L.P.

    F2 BIOSCIENCE GP LTD.

    F2 CAPITAL LTD

    PRIESTLEY KATHERINE

    GLOBEWAYS HOLDINGS LTD

    • 10% Owner
    No longer subject to file 2015-01-16 0

    F2 BIOSCIENCE IV L.P.

    F2 BIOSCIENCE IV GP LTD.

    F2 CAPITAL LTD

    PRIESTLEY KATHERINE

    F2 BIO VENTURES V L.P.

    F2 BIO VENTURES GP LTD.

    GLOBEWAYS HOLDINGS LTD

    • 10% Owner
    No longer subject to file 2015-01-16 0

    JOVAN-EMBIRICOS MORANA

    • Director
    • 10% Owner
    0 2015-01-08 0

    F2 BIOSCIENCE III, L.P.

    F2 BIOSCIENCE GP LTD.

    F2 CAPITAL LTD

    PRIESTLEY KATHERINE

    • 10% Owner
    1,167,997 2015-01-08 0

    HARRIS ALAN G CHIEF MEDICAL OFFICER

    • Officer
    0 2014-12-17 0

    STONER ELIZABETH

    • Director
    0 2014-12-17 0

    F2 BIOSCIENCE IV L.P.

    F2 BIOSCIENCE IV GP LTD.

    F2 CAPITAL LTD

    PRIESTLEY KATHERINE

    F2 BIO VENTURES V L.P.

    F2 BIO VENTURES GP LTD.

    GLOBEWAYS HOLDINGS LTD

    F2 BIOSCIENCE VI L.P.

    • 10% Owner
    3,254,334 2014-06-11 0

    F2 BIOSCIENCE VI L.P.

    F2 CAPITAL LTD

    PRIESTLEY KATHERINE

    GLOBEWAYS HOLDINGS LTD

    F2 BIOSCIENCE IV GP LTD.

    • 10% Owner
    587,500 2014-06-11 0

    DURAND MARK CHIEF COMMERCIAL OFFICER

    • Officer
    0 2014-06-05 0

    MPM BIOVENTURES IV LLC

    SCOPA JAMES PAUL

    VANDER VORT JOHN

    MPM BIOVENTURES IV GP LLC

    MPM BIO IV NVS STRATEGIC FUND LP

    FOLEY TODD

    KAILIAN VAUGHN M

    • 10% Owner
    179,095 2013-04-23 0

    WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST

    • 10% Owner
    0 2011-12-14 0

    MPM BIOVENTURES IV LLC

    MPM BIOVENTURES IV GP LLC

    MPM BIO IV NVS STRATEGIC FUND LP

    FOLEY TODD

    KAILIAN VAUGHN M

    SCOPA JAMES PAUL

    ST PETER STEVEN

    VANDER VORT JOHN

    • 10% Owner
    0 2011-12-14 0

    FLEMING JONATHAN

    • Director
    0 2011-12-14 0

    HEALTHCARE VENTURES VII LP

    HEALTHCARE PARTNERS VII, L.P.

    CAVANAUGH JAMES H

    LAWLOR AUGUSTINE

    LITTLECHILD JOHN W

    MIRABELLI CHRISTOPHER

    WERNER HAROLD R

    • 10% Owner
    0 2011-11-18 0

    LYTTLE CECIL RICHARD PRESIDENT AND CEO

    • Officer
    • Director
    0 2011-11-07 0

    O'DEA LOUIS SR. VP, CHIEF MEDICAL OFFICER

    • Officer
    0 2011-11-07 0

    MPM BIOVENTURES IV LLC

    MPM BIOVENTURES IV GP LLC

    MPM BIO IV NVS STRATEGIC FUND LP

    DOMBKOWSKI ASHLEY L

    GREENE WILLIAM

    KAILIAN VAUGHN M

    SCOPA JAMES PAUL

    ST PETER STEVEN

    VANDER VORT JOHN

    • 10% Owner
    0 2011-05-17 0

    IPSEN PHARMA SAS

    IPSEN, S.A.

    • 10% Owner
    • POSSIBLE 10% BENEFICIAL OWNER
    0 2011-05-17 0

    ST PETER STEVEN PRESIDENT

    • Officer
    • Director
    0 2008-06-15 0

    VANDER VORT JOHN SECRETARY

    • Officer
    • Director
    0 2008-06-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    RADIUS HEALTH INC RDUS 2022-08-15 22:15:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 21:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 21:15:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 20:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 20:15:03 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 19:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 19:15:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 18:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 18:15:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 17:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 17:15:03 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 16:45:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 16:15:04 UTC 1.4272 0.8928 3200000
    RADIUS HEALTH INC RDUS 2022-08-15 15:45:04 UTC 1.4272 0.8928 100000
    RADIUS HEALTH INC RDUS 2022-08-15 15:15:04 UTC 1.4272 0.8928 90000
    RADIUS HEALTH INC RDUS 2022-08-15 14:45:04 UTC 1.4272 0.8928 90000
    RADIUS HEALTH INC RDUS 2022-08-15 14:15:03 UTC 1.4272 0.8928 90000
    RADIUS HEALTH INC RDUS 2022-08-15 13:45:04 UTC 1.4607 0.8593 90000
    RADIUS HEALTH INC RDUS 2022-08-15 13:15:04 UTC 1.4607 0.8593 90000
    RADIUS HEALTH INC RDUS 2022-08-15 12:45:04 UTC 1.4607 0.8593 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund RDUS -1200.0 shares, $-14892.0 2021-09-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio RDUS -19600.0 shares, $-243236.0 2021-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments